Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review

A Single Strain of Lactobacillus (CGMCC 21661) Exhibits Stable Glucose- and Lipid-Lowering Effects by Regulating Gut Microbiota

(2023) Yuying Wang et al.   Nutrients

Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis

(2023) Nhan H T Pham et al.   NUTRITION REVIEWS

Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes

(2023) Yu-Dian Zhou et al.   Frontiers in Microbiology

Down‐to‐Earth Studies of the Gut Microbiome in Bone Health and Disease

(2022) Ruolin Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Environmental factors shaping the gut microbiome in a Dutch population

(2022) R. Gacesa et al.   NATURE

First Report of Bacterial Leaf Spot of Ficus benghalensis Caused by Pseudomonas cichorii in Pakistan

(2022) Tanvir Ahmad et al.   PLANT DISEASE

Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial

(2022) Xiuying Zhang et al.   DIABETOLOGIA

Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota

(2022) Koji Hosomi et al.   Nature Communications

Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people

(2021) Shu-chun Li et al.   JOURNAL OF MICROBIOLOGY

Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus

(2021) Junjie Shang et al.   PeerJ

Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes

(2021) M. Nazmul Huda et al.   Frontiers in Endocrinology

Metformin reduces blood glucose in treatment-naive type 2 diabetes by altering the gut microbiome

(2021) Daqiang HE et al.   Canadian Journal of Diabetes

The gut microbiome and type 2 diabetes status in the Multiethnic Cohort

(2021) Gertraud Maskarinec et al.   PLoS One

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes

(2021) Fumie Takewaki et al.   Nutrients

Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality

(2021) Qi Zhang et al.   Frontiers in Psychiatry

Influence of Lactobacillus paracasei HII01 Supplementation on Glycemia and Inflammatory Biomarkers in Type 2 Diabetes: A Randomized Clinical Trial

(2021) Parichart Toejing et al.   Foods

Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity

(2021) Zhangling Chen et al.   JAMA Network Open

The ambivalent role of Bacteroides in enteric infections

(2021) Elise Bornet et al.   TRENDS IN MICROBIOLOGY

Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans

(2020) Ayo P. Doumatey et al.   Frontiers in Cellular and Infection Microbiology

Role of gut microbiota in type 2 diabetes pathophysiology

(2020) Manoj Gurung et al.   EBioMedicine

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

(2020) Judith Aron-Wisnewsky et al.   Nature Reviews Gastroenterology & Hepatology

The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health

(2020) Bianca J. Parker et al.   Frontiers in Immunology

The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis

(2020) Patricia M. Bock et al.   DIABETOLOGIA

Pathophysiology of Type 2 Diabetes Mellitus

(2020) Unai Galicia-Garcia et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents

(2020) Babiker Saad Almugadam et al.   Journal of Diabetes Research

The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study

(2020) Hanako Nakajima et al.   Life-Basel

Alteration of gut microbiota by a westernized lifestyle and its correlation with insulin resistance in non‐diabetic Japanese men

(2019) Mami Yamashita et al.   Journal of Diabetes Investigation

Prevotella copri in individuals at risk for rheumatoid arthritis

(2019) Deshire Alpizar-Rodriguez et al.   ANNALS OF THE RHEUMATIC DISEASES

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes

(2019) E.J.M. van Bommel et al.   DIABETES & METABOLISM

Type-2 Diabetics Reduces Spatial Variation of Microbiome Based on Extracellur Vesicles from Gut Microbes across Human Body

(2019) Geumkyung Nah et al.   Scientific Reports

Valerate production by Megasphaera elsdenii isolated from pig feces

(2018) Shota Yoshikawa et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial

(2018) Xiaolin Tong et al.   mBio

Gut microbiota modulates drug pharmacokinetics

(2018) Juanhong Zhang et al.   DRUG METABOLISM REVIEWS

Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment

(2018) Min Li et al.   Frontiers in Physiology

Metformin action through the microbiome and bile acids

(2018) Grace L. Guo et al.   NATURE MEDICINE

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

(2018) Lulu Sun et al.   NATURE MEDICINE

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?

(2018) Jessica D. Forbes et al.   Microbiome

Bi-directional drug-microbiome interactions of anti-diabetics

(2018) Andrew Whang et al.   EBioMedicine

Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats

(2017) Fen Zhang et al.   JOURNAL OF DAIRY SCIENCE

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

(2017) Hao Wu et al.   NATURE MEDICINE

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

(2017) Yanyun Gu et al.   Nature Communications

Metformin Is Associated With Higher Relative Abundance of Mucin-DegradingAkkermansia muciniphilaand Several Short-Chain Fatty Acid–Producing Microbiota in the Gut

(2016) Jacobo de la Cuesta-Zuluaga et al.   DIABETES CARE

Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial

(2016) Somayyeh Firouzi et al.   EUROPEAN JOURNAL OF NUTRITION

Mechanisms Linking the Gut Microbiome and Glucose Metabolism

(2016) Kristina M. Utzschneider et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

Bifidobacterium species lower serum glucose, increase expressions of insulin signaling proteins, and improve adipokine profile in diabetic mice

(2015) Thi Kim Chung LE et al.   BIOMEDICAL RESEARCH-TOKYO

The influence of gut microbiota on drug metabolism and toxicity

(2015) Houkai Li et al.   Expert Opinion on Drug Metabolism & Toxicology

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

(2015) Kristoffer Forslund et al.   NATURE

Discovery and Characterization of Gut Microbiota Decarboxylases that Can Produce the Neurotransmitter Tryptamine

(2014) Brianna B. Williams et al.   Cell Host & Microbe

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

(2014) Anila K. Madiraju et al.   NATURE

Metformin—mode of action and clinical implications for diabetes and cancer

(2014) Ida Pernicova et al.   Nature Reviews Endocrinology

Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice

(2014) Yanjun Ma et al.   PLoS One

Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus

(2014) Antonella Napolitano et al.   PLoS One

The effect of gut microbiota on drug metabolism

(2013) Mi Jeong Kang et al.   Expert Opinion on Drug Metabolism & Toxicology

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

(2013) Russell A. Miller et al.   NATURE

Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice

(2012) Yan Y. Lam et al.   PLoS One

Enterotypes of the human gut microbiome

(2011) Manimozhiyan Arumugam et al.   NATURE

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

(2010) Marc Foretz et al.   JOURNAL OF CLINICAL INVESTIGATION

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE